News & views: anti-amyloid antibodies and novel emerging approaches to Alzheimer's disease in 2023

被引：8
作者：
Gandy, Sam [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, NIA Designated Mt Sinai Alzheimers Dis Res Ctr, New York, NY 10029 USA
[3] James J Peters VA Med Ctr, Bronx, NY 10468 USA
[4] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Mt Sinai Ctr Cognit Hlth, New York, NY 10029 USA
来源：
MOLECULAR NEURODEGENERATION | 2023年 / 18卷 / 01期
关键词：
Aducanumab; Bapineuzumab; Donanemab; Lecanemab;
D O I：
10.1186/s13024-023-00656-x
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页数：3
相关论文
共 12 条
[1]   New approaches to symptomatic treatments for Alzheimer's disease [J].
Cummings, Jeffrey .
MOLECULAR NEURODEGENERATION, 2021, 16 (01)
[2]   Immunotherapy targeting pyroglutamate-3 Aβ: prospects and challenges [J].
Cynis, Holger ;
Frost, Jeffrey L. ;
Crehan, Helen ;
Lemere, Cynthia A. .
MOLECULAR NEURODEGENERATION, 2016, 11
[3]   Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA [J].
Gandy, Sam ;
Knopman, David S. ;
Sano, Mary .
MOLECULAR NEURODEGENERATION, 2021, 16 (01)
[4]   Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease [J].
Guo, Tiantian ;
Zhang, Denghong ;
Zeng, Yuzhe ;
Huang, Timothy Y. ;
Xu, Huaxi ;
Zhao, Yingjun .
MOLECULAR NEURODEGENERATION, 2020, 15 (01)
[5]   ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease [J].
Honig, Lawrence S. ;
Barakos, Jerome ;
Dhadda, Shobha ;
Kanekiyo, Michio ;
Reyderman, Larisa ;
Irizarry, Michael ;
Kramer, Lynn D. ;
Swanson, Chad J. ;
Sabbagh, Marwan .
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2023, 9 (01)
[6]   TREM2 dependent and independent functions of microglia in Alzheimer's disease [J].
Hou, Jinchao ;
Chen, Yun ;
Grajales-Reyes, Gary ;
Colonna, Marco .
MOLECULAR NEURODEGENERATION, 2022, 17 (01)
[7]   ApoE in Alzheimer's disease: pathophysiology and therapeutic strategies [J].
Raulin, Ana-Caroline ;
Doss, Sydney, V ;
Trottier, Zachary A. ;
Ikezu, Tadafumi C. ;
Bu, Guojun ;
Liu, Chia-Chen .
MOLECULAR NEURODEGENERATION, 2022, 17 (01)
[8]  
Sims JR, 2023, JAMA-J AM MED ASSOC, V330, P512, DOI [10.1136/dtb.2024.000020, 10.1001/jama.2023.13239]
[9]   A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody [J].
Swanson, Chad J. ;
Zhang, Yong ;
Dhadda, Shobha ;
Wang, Jinping ;
Kaplow, June ;
Lai, Robert Y. K. ;
Lannfelt, Lars ;
Bradley, Heather ;
Rabe, Martin ;
Koyama, Akihiko ;
Reyderman, Larisa ;
Berry, Donald A. ;
Berry, Scott ;
Gordon, Robert ;
Kramer, Lynn D. ;
Cummings, Jeffrey L. .
ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
[10]  
van Dyck CH, 2023, NEW ENGL J MED, V388, P9, DOI [10.1056/NEJMoa2212948, 10.1056/NEJMc2301380]
12